BACKGROUND: Genetic variants that affect estrogen activity may influence the risk of Alzheimer's disease (AD). Two tightly linked polymorphisms (PvuII and XbaI) in the first intron of estrogen receptor 1 (ESR1), the gene for ER-alpha, have been reported to influence estrogen receptor expression and may influence the risk of AD. METHODS: We examined the relation of polymorphisms in ESR1 to the risk of AD in women with Down syndrome. The subjects (181 women with DS, 41-78 years of age) were followed at 14- to 18-month intervals. Information from cognitive assessments, caregiver interviews, medical record reviews and neurological examinations was used to classify dementia. Genomic DNA was genotyped for 5 single-nucleotide polymorphisms in the upstream region and the first exon/intron of the ESR1 gene. Their association with dementia risk was evaluated, adjusting for covariates. RESULTS: Women with at least 1 copy of the C allele at rs2234693 (PvuII) and those homozygous for the C allele at rs2077647 had an almost 3-fold increase in the risk of AD, compared with women without the C allele. The increased risks were independent of the apolipoprotein E genotype. CONCLUSION: These findings support a role for estrogen receptor activity in the development of AD in women with Down syndrome. (c) 2008 S. Karger AG, Basel
BACKGROUND: Genetic variants that affect estrogen activity may influence the risk of Alzheimer's disease (AD). Two tightly linked polymorphisms (PvuII and XbaI) in the first intron of estrogen receptor 1 (ESR1), the gene for ER-alpha, have been reported to influence estrogen receptor expression and may influence the risk of AD. METHODS: We examined the relation of polymorphisms in ESR1 to the risk of AD in women with Down syndrome. The subjects (181 women with DS, 41-78 years of age) were followed at 14- to 18-month intervals. Information from cognitive assessments, caregiver interviews, medical record reviews and neurological examinations was used to classify dementia. Genomic DNA was genotyped for 5 single-nucleotide polymorphisms in the upstream region and the first exon/intron of the ESR1 gene. Their association with dementia risk was evaluated, adjusting for covariates. RESULTS:Women with at least 1 copy of the C allele at rs2234693 (PvuII) and those homozygous for the C allele at rs2077647 had an almost 3-fold increase in the risk of AD, compared with women without the C allele. The increased risks were independent of the apolipoprotein E genotype. CONCLUSION: These findings support a role for estrogen receptor activity in the development of AD in women with Down syndrome. (c) 2008 S. Karger AG, Basel
Authors: E Porrello; M C Monti; E Sinforiani; M Cairati; A Guaita; C Montomoli; S Govoni; M Racchi Journal: Eur J Neurol Date: 2006-06 Impact factor: 6.089
Authors: H Maruyama; H Toji; C R Harrington; K Sasaki; Y Izumi; T Ohnuma; H Arai; M Yasuda; C Tanaka; P C Emson; S Nakamura; H Kawakami Journal: Arch Neurol Date: 2000-02
Authors: K M Mattila; K Axelman; J O Rinne; M Blomberg; T Lehtimäki; P Laippala; M Röyttä; M Viitanen; L Wahlund; B Winblad; L Lannfelt Journal: Neurosci Lett Date: 2000-03-17 Impact factor: 3.046
Authors: M L Brandi; L Becherini; L Gennari; M Racchi; A Bianchetti; B Nacmias; S Sorbi; P Mecocci; U Senin; S Govoni Journal: Biochem Biophys Res Commun Date: 1999-11-19 Impact factor: 3.575
Authors: Patrick J Lao; José Gutierrez; David Keator; Batool Rizvi; Arit Banerjee; Kay C Igwe; Krystal K Laing; Mithra Sathishkumar; Fahmida Moni; Howard Andrews; Sharon Krinsky-McHale; Elizabeth Head; Joseph H Lee; Florence Lai; Michael A Yassa; H Diana Rosas; Wayne Silverman; Ira T Lott; Nicole Schupf; Adam M Brickman Journal: Ann Neurol Date: 2020-10-09 Impact factor: 10.422
Authors: Qi Zhao; Joseph H Lee; Deborah Pang; Alexis Temkin; Naeun Park; Sarah C Janicki; Warren B Zigman; Wayne Silverman; Benjamin Tycko; Nicole Schupf Journal: Dement Geriatr Cogn Disord Date: 2011-12-08 Impact factor: 2.959